134 related articles for article (PubMed ID: 34225608)
1. The Role of Tumor-related LncRNA PART1 in Cancer.
Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122.
Hu X; Zhang L; Tian J; Ma J
World J Surg Oncol; 2021 Apr; 19(1):122. PubMed ID: 33865422
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PART1 inhibits glioma proliferation and migration via miR-374b/SALL1 axis.
Deng YW; Shu YG; Sun SL
Neurochem Int; 2022 Jul; 157():105347. PubMed ID: 35490895
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2.
Han H; Wang S; Meng J; Lyu G; Ding G; Hu Y; Wang L; Wu L; Yang W; Lv Y; Jia S; Zhang L; Ji J
Oncogene; 2020 Oct; 39(42):6513-6528. PubMed ID: 32901105
[TBL] [Abstract][Full Text] [Related]
5. LncRNA
Wang J; Han Y; Zhang T; Li J; Xu B
Front Biosci (Landmark Ed); 2023 Oct; 28(10):270. PubMed ID: 37919051
[TBL] [Abstract][Full Text] [Related]
6. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PART1 facilitates the malignant progression of colorectal cancer via miR-150-5p/LRG1 axis.
Lou T; Ke K; Zhang L; Miao C; Liu Y
J Cell Biochem; 2020 Oct; 121(10):4271-4281. PubMed ID: 31898365
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PART1 regulates colorectal cancer via targeting miR-150-5p/miR-520h/CTNNB1 and activating Wnt/β-catenin pathway.
Zhou T; Wu L; Ma N; Tang F; Zong Z; Chen S
Int J Biochem Cell Biol; 2020 Jan; 118():105637. PubMed ID: 31669140
[TBL] [Abstract][Full Text] [Related]
9. AGAP2-AS1: An Indispensable lncRNA in Tumors.
Chen J; Wang B
Mini Rev Med Chem; 2023; 23(3):336-342. PubMed ID: 35708074
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PART1 modulates toll-like receptor pathways to influence cell proliferation and apoptosis in prostate cancer cells.
Sun M; Geng D; Li S; Chen Z; Zhao W
Biol Chem; 2018 Mar; 399(4):387-395. PubMed ID: 29261512
[TBL] [Abstract][Full Text] [Related]
11. Silencing of lncRNA PART1 inhibits proliferation, invasion and migration of breast cancer cells and promotes the efficacy of cisplatin in breast cancer cells.
Zhang L; Zhang J; Ni C
Gen Physiol Biophys; 2020 Jul; 39(4):343-354. PubMed ID: 32700682
[TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA PART1: dual role in cancer.
Ran R; Gong CY; Wang ZQ; Zhou WM; Zhang SB; Shi YQ; Ma CW; Zhang HH
Hum Cell; 2022 Sep; 35(5):1364-1374. PubMed ID: 35864416
[TBL] [Abstract][Full Text] [Related]
13. LncRNA PART1 Stimulates the Development of Ovarian Cancer by Up-regulating RACGAP1 and RRM2.
Li H; Lei Y; Li S; Li F; Lei J
Reprod Sci; 2022 Aug; 29(8):2224-2235. PubMed ID: 35553409
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2.
Zhou J; Che J; Xu L; Yang W; Zhou W; Zhou C
Dig Liver Dis; 2022 Apr; 54(4):543-553. PubMed ID: 34497040
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
Yu Q; Du Y; Wang S; Zheng X
J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
[TBL] [Abstract][Full Text] [Related]
16.
Yang H; Zhang X; Zhu L; Yang Y; Yin X
DNA Cell Biol; 2021 Jun; 40(6):821-832. PubMed ID: 34030482
[TBL] [Abstract][Full Text] [Related]
17. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PART1 modulates chondrocyte proliferation, apoptosis, and extracellular matrix degradation in osteoarthritis via regulating miR-373-3p/SOX4 axis.
Zhu YJ; Jiang DM
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8175-8185. PubMed ID: 31646607
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA PART1 promotes progression of non-small cell lung cancer cells via JAK-STAT signaling pathway.
Zhu D; Yu Y; Wang W; Wu K; Liu D; Yang Y; Zhang C; Qi Y; Zhao S
Cancer Med; 2019 Oct; 8(13):6064-6081. PubMed ID: 31436388
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PART1 promotes lung squamous cell carcinoma progression via miR-185-5p/Six1 axis.
Cao Y; Zhang R; Luo X; Yang Y
Hum Exp Toxicol; 2021 Jun; 40(6):960-976. PubMed ID: 33300377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
